Surprisingly, we did not find any patient with either deletion or duplication of exons 2–6 in UBE2T, thus demonstrating that the frequency of aluY-mediated genomic rearrangements in the UBE2T locus was not increased in this cancer patient population (Fig. 5B). Here, UBE2T is linked to cancer.